The CD133 antigen is commonly used to identify normal and CSCs, and anti-EpCAM staining was performed in this study because this molecule is often overexpressed in lung cancers, although its functional role in forming metastases remains controversial (van der Gun et al. 2010). This evidence concerns the gene PROM1 and lung carcinoma.